D.A. Davidson & Co’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-13,958
| Closed | -$23K | – | 1174 |
|
2017
Q4 | $23K | Buy |
+13,958
| New | +$23K | ﹤0.01% | 1104 |
|
2017
Q3 | – | Sell |
-8,016
| Closed | -$12K | – | 2303 |
|
2017
Q2 | $12K | Sell |
8,016
-4,628
| -37% | -$6.93K | ﹤0.01% | 1996 |
|
2017
Q1 | $43K | Sell |
12,644
-1,454
| -10% | -$4.95K | ﹤0.01% | 1576 |
|
2016
Q4 | $73K | Sell |
14,098
-25,615
| -65% | -$133K | ﹤0.01% | 1448 |
|
2016
Q3 | $1M | Buy |
39,713
+31,969
| +413% | +$805K | 0.02% | 467 |
|
2016
Q2 | $191K | Buy |
7,744
+75
| +1% | +$1.85K | 0.01% | 860 |
|
2016
Q1 | $222K | Buy |
+7,669
| New | +$222K | 0.01% | 798 |
|
2015
Q4 | – | Sell |
-375
| Closed | -$18K | – | 2325 |
|
2015
Q3 | $18K | Sell |
375
-250
| -40% | -$12K | ﹤0.01% | 1705 |
|
2015
Q2 | $43K | Buy |
625
+262
| +72% | +$18K | ﹤0.01% | 1494 |
|
2015
Q1 | $12K | Buy |
+363
| New | +$12K | ﹤0.01% | 1768 |
|